top of page
![IMG_9456 (1)-2.jpg](https://static.wixstatic.com/media/2cacca_3f51cddc7c924252bd1eefcb1045f35a~mv2.jpg/v1/fill/w_980,h_469,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/2cacca_3f51cddc7c924252bd1eefcb1045f35a~mv2.jpg)
DigiBeat News
![](https://static.wixstatic.com/media/2cacca_ca546d90b4734e2ab068cf287c093617~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/2cacca_ca546d90b4734e2ab068cf287c093617~mv2.webp)
![New Drug Development: Mitigating Concerns Over Adverse Cardiac Events with DigiBeat Monitoring](https://static.wixstatic.com/media/2cacca_ca546d90b4734e2ab068cf287c093617~mv2.jpg/v1/fill/w_292,h_219,fp_0.50_0.50,q_90,enc_auto/2cacca_ca546d90b4734e2ab068cf287c093617~mv2.webp)
3 min read
New Drug Development: Mitigating Concerns Over Adverse Cardiac Events with DigiBeat Monitoring
Introduction: As pharmaceutical companies strive to introduce novel therapeutics, concerns regarding adverse cardiac events loom large....
bottom of page